Cross-Validation of Single-Stage Treadmill Tests for Predicting Aerobic Fitness in Adolescents With Type I Diabetes

in Pediatric Exercise Science
Restricted access

Purchase article

USD  $24.95

Student 1 year subscription

USD  $68.00

1 year subscription

USD  $90.00

Student 2 year subscription

USD  $129.00

2 year subscription

USD  $168.00

Purpose:

Determining fitness is important when assessing adolescents with type 1 diabetes mellitus (T1DM). Submaximal tests estimate fitness, but none have been validated in this population. This study cross-validates the Ebbeling and Nemeth equations to predict fitness (VO2max (ml/kg/min)) in adolescents with T1DM.

Methods:

Adolescents with T1DM (n = 20) completed a maximal treadmill test using indirect calorimetry. Participants completed one 4-min stage between 2.0 and 4.5 mph and 5% grade (Ebbeling/Nemeth protocol). Speed and grade were then increased until exhaustion. Predicted VO2max was calculated using the Ebbeling and Nemeth equations and compared with observed VO2max using paired t tests. Pearson correlation coefficients, 95% confidence intervals, coefficients of determination (R2), and total error (TE) were calculated.

Results:

The mean observed VO2max was 47.0 ml/kg/min (SD = 6.9); the Ebbeling and Nemeth mean predictions were 42.4 (SD = 9.4) and 43.5 ml/kg/min (SD = 6.9), respectively. Paired t tests resulted in statistically significant (p < .01) mean differences between observed and predicted VO2max for both predictions. The association between the Ebbeling prediction and observed VO2max was r = .90 (95% CI = 0.76, 0.96), R 2 = .81, and TE = 6.5 ml/kg/min. The association between the Nemeth prediction and observed VO2max was r = .81 (95% CI = 0.57, 0.92), R 2 = .66, and TE = 5.6 ml/kg/min.

Conclusion:

The Nemeth submaximal treadmill protocol provides a better estimate of fitness than the Ebbeling in adolescents with T1DM.

Francis and Janz are with the Dept. of Health and Human Physiology, Tsalikian the Dept. of Pediatrics, and Tansey the Dept. of Endocrinology, University of Iowa, Iowa City, IA. Singhvi is with the McGaw Medical Center, Northwestern University, Chicago, IL.

Address author correspondence to Shelby Lane Francis at shelby-francis@uiowa.edu.